Colorectal Surgery

Colorectal Surgery

  • Overview
  • Approach
  • Recommended For
  • Appointments

    • University of Michigan Health is renowned for its highest level of care in diagnosis and treatment surgical care and post-operative management of complex colorectal disorders affecting the intestines, rectum and anus. Our expert group of board-certified colorectal surgery specialists offers minimally invasive surgical approaches, including laparascopic colorectal surgery and robotic colorectal surgery, for the treatment of colon and rectal cancer, inflammatory bowel disease, diverticulitis, rectal prolapse and other colorectal conditions.

    Our Approach

    Our highly skilled surgeons are committed to delivering care based on the latest evidence based surgical and medical techniques and research discoveries. A multidisciplinary team of enterostomal therapists, nurses, nutritionists, physical therapists, physician assistants, social workers and allied health professionals are a part of the team supporting healing and quality of life.

    Appointment Information

    To schedule an appointment with a colorectal surgeon, please call us at (734) 936-5738.

    Patients will have access to all of the resources available at our facility including consultation with gastroenterologists, gynecologists, urologists, medical oncologists, radiation oncologists and other disciplines as warranted. We are part of the University of Michigan Comprehensive Cancer Center and the Michigan Bowel Control Program.

    News & Stories
    Man in a blue pullover against the background of Michigan Stadium
    Health Lab

    Thriving after a rectal cancer diagnosis

    Kyle Kipke was diagnosed with rectal cancer and received chemotherapy and radiation as treatment at Michigan Medicine.
         family posing together
    Health Lab

    Doctors perform first liver transplant in Michigan for colon cancer

    Andrew Sweeney was diagnosed with stage 4 colorectal cancer at age 31 and underwent a liver transplant, chemotherapy and radiation treatment.
         Cancer Aware surrounded by a circle of multicolor ribbons
    Cancer Aware

    Cutting edge treatment for advanced colon cancer

    Andrew Sweeney, now 35, was aware of his risk for colorectal cancer – his mother had had been diagnosed with it when she was 41. When he was 31, a CT scan at University of Michigan Health’s University Hospital revealed that Sweeney had a mass in his colon and potential metastases in his liver and lymph nodes. A colonoscopy confirmed that he had stage 4 colorectal cancer. After 1.5 years of chemotherapy, his care team began discussing how they could remove the damaged parts of Sweeney’s liver. They developed a colorectal cancer liver transplant protocol from a deceased donor and Sweeney was the first patient to undergo a liver transplant in Michigan for colon cancer. After minor recurrences of tumors in his lung in 2024, which were treated by surgery and radiation, his scans have been clear.
         intestines red with red dot
    Health Lab

    Colorectal cancer is no longer just a disease of older adults

    With colorectal (CRC) on the rise in younger patients, a specialist in gastroenterology and human genetics discusses why that may be and what to look for.
         microscope drawing yellow navy
    Health Lab

    Glucose drives STAT3 activation in colorectal cancer cells, leading to tumor growth

    University of Michigan researchers have shown that glucose levels sustain the increased STAT3 activation in colorectal cancer cells. Their findings suggest that targeting glucose metabolism could inhibit STAT3, leading to novel therapeutic strategies.
         ribbons in colorful colors lined up next to eachother
    Health Lab

    5-year survival rate has increased for all cancers, according to American Cancer Society

    The American Cancer Society reports that mortality rates have continued to decline since the 1990s. N. Lynn Henry, of Michigan Medicine, answers questions about how factors such as healthy lifestyle choices, early screening and clinical trials have improved cancer survival rates.